Investing News NetworkYour trusted source for investing success

newlink genetics

NewLink Genetics Receives European Commission Grant of Conditional Marketing Approval for V920

5 Top NASDAQ Biotech and Pharma Stocks: Constellation Leads

NewLink Genetics and Lumos Pharma to Form Biopharma Company

NewLink Genetics Receives FDA Acceptance for Partnered Biologics License Application

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Sesen Bio Up 40 Percent

NewLink Genetics Presents Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019

NewLink Genetics Announces Merck Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920

NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients

NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results

NewLink Genetics To Present New Data from Phase 1b Study

QEM Appoints Robert Cooper as Director, following Leadership Transition

Blackstone Secures $22.6m for Mankayan Copper-Gold Drilling

C29 Metals shifts focus to Mayfield Copper Project

Equity Metals: Advancing High-grade, District-scale Silver and Gold Assets in British Columbia

South Harz Potash: A Globally Significant European Potash and Critical Minerals Opportunity

South Harz Potash Limited

Equity Metals

Terra Clean Energy

BP

NevGold

FinEx Metals

MARKETS

COMMODITIES

CURRENCIES